Haloxyl (Chrysin + Palmitoyl Peptides)
Overview
Haloxyl is a combination ingredient consisting of chrysin, a naturally occurring flavone, and palmitoyl oligopeptides designed to address periorbital hyperpigmentation and edema. The chrysin component is thought to activate enzyme systems involved in bilirubin and hemoglobin clearance, while the palmitoyl peptides enhance dermal penetration and stimulate lymphatic drainage.
Mechanism of Action
This dual-mechanism approach targets the appearance of dark circles attributable to both vascular congestion and iron deposition.
Research Summary & Key Findings
Manufacturer-sponsored studies reported reductions in periorbital pigmentation and puffiness assessed by chromametry and clinical grading, though independent replication in peer-reviewed dermatology literature is limited. The evidence base consists primarily of in vitro permeability studies and small open-label human trials without published long-term safety data.
Clinical Status
Haloxyl (Chrysin + Palmitoyl Peptides) is in the research phase with limited clinical data in humans. Current evidence is primarily derived from preclinical (animal or in vitro) studies.
Administration Routes
References
Primary literature
- PubMed — "Haloxyl"
Peer-reviewed literature indexed by the National Library of Medicine.
- ClinicalTrials.gov — "Haloxyl"
Registered interventional and observational studies, including status and phase.
- PubChem — "Haloxyl"
Chemical structure, molecular properties, and bioactivity data.
Study-level citations for this compound are being verified against the primary sources before publication. The database queries above return the current indexed literature in the meantime.
Related Peptides in Dermatology
Afamelanotide (Scenesse)
FDA ApprovedA synthetic 13-amino acid analog of alpha-melanocyte-stimulating hormone (alpha-MSH) with a substitution of norleucine a...
View detailsArgireline (Acetyl Hexapeptide-8)
InvestigationalArgireline is a synthetic six amino acid peptide (Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2) designed to attenuate neurotransmitter...
View detailsMatrixyl (Palmitoyl Pentapeptide-4)
InvestigationalMatrixyl is a lipopeptide composed of a pentapeptide sequence (Lys-Thr-Thr-Lys-Ser) attached to a palmitic acid moiety t...
View detailsMatrixyl 3000
InvestigationalMatrixyl 3000 is a proprietary combination of two lipopeptides: palmitoyl tripeptide-1 (Pal-GHK) and palmitoyl tetrapept...
View detailsStart Your Consultation
Get an AI-proposed Haloxyl (Chrysin + Palmitoyl Peptides) protocol reviewed by a physician in our network.
Start Your ConsultationFind a Pharmacy
Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Haloxyl (Chrysin + Palmitoyl Peptides).
Pharmacy DirectoryJoin the Association
Access exclusive peptide protocols, provider resources, and community support.
List Your PracticeDisclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol. See our editorial policy for how this content is produced and reviewed.